Caplin Point Laboratories Ltd

NSE: CAPLIPOINT · BSE: 524742 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹2,638.00
Market cap: ₹20,052 Cr
Revenue (annual): ₹2,187 Cr
Net profit (annual): ₹641.2 Cr
P/E (TTM): 30.1×Sector 47.4×
Promoter holding: 70.57%+0.00% QoQ
FII holding: 5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Earnings Call 4 Financial Results 3 Regulatory Approval 2 Price Movement Clarification 2 Dividend 2 Business Update 2 Board Meeting Date 2 Annual General Meeting 2 Management Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

12 Aug 2026 13:32 IST NSE

Financial Results

Caplin Point Laboratories Q1 FY27 Results: Net Profit ₹179.1 Cr, Up 18.8% YoY

Caplin Point Laboratories Ltd reported revenue from operations of ₹610.4 Cr (+19.6% YoY) and net profit of ₹179.1 Cr (+18.8% YoY) for Q1 FY27.

Key figure: Net profit ₹179.1 Cr · +18.8% YoY

Open full results → Read the filing ↗

14 May 2026 13:17 IST BSE

Financial Results

Caplin Point Laboratories Q4 FY26 Results: Net Profit ₹172.9 Cr, Up 19.0% YoY

Caplin Point Laboratories Ltd reported revenue from operations of ₹600.2 Cr (+19.5% YoY) and net profit of ₹172.9 Cr (+19.0% YoY) for Q4 FY26.

Key figure: Net profit ₹172.9 Cr · +19.0% YoY

Open full results → Read the filing ↗

14 May 2026 13:16 IST BSE

Financial Results

Caplin Point Laboratories Financial Results

Caplin Point Laboratories reported FY26 consolidated revenue of ₹2,187.19 Crore and PAT of ₹649.73 Crore. The Board also declared an interim dividend of ₹4 per share.

Read the filing ↗